Orphan Drug
We are currently looking to understand the pharma distribution strategy adopted by orphan drug (drugs to treat rare disease) manufacturers in australia. We know that australian market is dominated by three major cso distributors (api, sigma and x
b) and major generic drug manufacturers prefer to engage with these 3 wholesalers as they have the maximum distribution point of sales and are required to supply drugs listed in pbs.
1. So based on this, would like to know if orphan drug manufacturers also use these wholesalers or do they prefer direct distribution using dhl or world couriers, or any other strategy?
2. Would like to get some case specific to orphan drug distribution in australia.
Thank you and looking forward.
+10 Other ResponsesDrugs With Current/expired Patents
Looking for c-level responses from manufacturers of drugs with current and/or expired patents to take to china via established distribution network that handles sfda, regulatory/government relationships as well national, regional and local distribution channels.
+12 Other ResponsesPharma Research Interviewees
We are seeking highest specialized experts with experience in the life sciences industry - must meet below specifications
location: usa - san fransisco bay area, los angeles, philadelphia, new york, boston.
Industry: pharmaceuticals, contract development and manufacturing organizations (cdmos)/clinical research organizations (cros), and life science market research.
Testing availability: late june - early july
study 1: qualitative study - focus group interviews with 3 groups (6-8 respondents per group)
**respondent profile**:
group 1: 6-8 pharmaceutical executives from top 20 biotech companies who are influencers, contributors or decision makers on outsourcing services to contract development and manufacturing organizations (cdmos)/clinical research organizations (cros).
Group 2: 6-8 pharmaceutical executives from top 10 clinical research organizations (cros) companies who are influencers, contributors or decision makers on outsourcing services to contract development and manufacturing organizations (cdmos)/contract research organizations.
Group 3: 6-8 pharmaceutical executives from small / mid-sized pharmaceutical companies who are influencers, contributors or decision makers on outsourcing services to contract development and manufacturing organizations (cdmos)/contract research organizations.
**expert must have** a clear understanding of the following topics (doesn't have to be an expert at each level, but at least one, also a basic understanding of others):
a. Api services & chemical development – all stages of drug development for small molecules, potent and cytotoxic compounds, and peptides
b. Pharmaceutical development – development cycle of clinical candidate into an optimum formulation and clinical stages manufacturing
c. Analytical services – analytical services supporting drug substance (api) and drug product development including cmc regulatory filings
d. Clinical trial supply – clinical supplies, packaging, distribution and delivery of clinical protocols, supply chain management.
E. Clinical technologies - solutions for patient enrollment, screening randomization, drug assessment etc.
F. Commercial services – api supply, manufacturing, testing and packaging to end-user distribution.
+15 Other ResponsesPharmaceutical Pricing And Reimbursement
Pharmaceutical pricing and reimbursement stakeholders in spain, the netherlands, switzerland, brazil, mexico, argentina, japan, south korea, and china. A few specs of what we are looking for:
spain
member of key regional hta
chief pharmacist, planning and evaluation directorate, regional healthcare consortium
hospital pharmacists of major academic hospitals
brazil
current or previous employees of large private health insurers/hmo (e.G. Amil, unimed)
advisor to conitec
chief pharmacist at large private cancer hospitals
argentina
current or previous employees of trade-union health insurance funds (there are 300+ of them)
advisor, previous employees to pami
chief pharmacist at large private hospitals (e.G. Hospital italiano de buenos aires)
china
shanghai municipal food and drug administration
qingdao municipal bureau of human resource and social security
guangzhou municipal human resources and social security bureau
zhejiang province commission of health and family planning
+27 Other ResponsesActive Pharmaceutical Ingredients
I am looking for experts who can help me in understanding advances / trends in api manufacturing technologies. Please find below the list of questions for which i am looking for your support.
1. What are the various api manufacturing methods and what are the new technologies in each manufacturing method and what are the adoption rates?
2. Please provide the technology evolution of api manufacturing process
3. What are the upcoming technologies in manufacturing that can be applied to all types of apis
4. What are the technology trends or upcoming technologies with respect to the manufacturing following types of apis and what are their adoption rates? Please provide the examples of few companies that have adopted those new technologies:
• synthetic apis
• biotech apis that includes monoclonal antibodies and recombinant proteins
• hpapis – (highly potent active pharmaceutical ingredients)
5. Please provide technology trends, their adoption rates with respect to and their applicability to all types of apis: for example, if there is a new technology in solvent recovery, will it be applicable for all types of apis such as small molecule apis, synthetic apis and all other types.
• small molecule manufacturing,
• microbial and mammalian protein expression,
• monoclonal antibody production,
• advanced process controls,
• solvent recovery,
• effluent treatment,
• continuous processing,
• particle engineering,
• downstream product recovery processing (filtration, sedimentation, centrifugation, extraction, precipitation, adsorption, membrane separation, chromatography, crystallization, and drying),
• process analytical methodology,
+14 Other ResponsesPharmacovigilance Business Development
Job title: business development manager
job location: open (us and uk)
job type: full-time
please note: this position is only open to u.S. And u.K residents seeking full-time employment. No consultants please.
Position summary:
will work collaboratively with other colleagues to increase sales within the life sciences industry. Responsibilities will include full cycle sales including; researching, identifying, cold/warm calling, getting client meetings, listening and understanding client needs, addressing client concerns/objections, proposing solutions, negotiating, obtaining sows and closing the deal. Are expected to quickly develop credibility with customers/prospects and build trust through professionalism and knowledge of our services and products.
**essential duties and responsibilities**:
- prospect accounts focusing on safety related to our products and services
- identify and develop new accounts and following up on existing leads
- develop and maintain positive and productive relationships with key target accounts
- manage assigned accounts to generate both incremental and repeatable annual business
- initiate and manage rfi and rfp process and negotiate terms for all account programs and projects
- work collaboratively with the services organization to ensure a complete and professional delivery of our software and service solutions
- collaborate with our executives and smes to maximize account coverage
- maintain knowledgeable understanding of changing regulatory guidelines and mandates affecting the industry community
**job experience and qualifications**:
- must demonstrate a sustained (7+ years) and successful track record selling professional services to pharmaceutical, biotech, medical device, and/or clinical research organizations.
- selling drug safety consulting services and products is desired.
- candidates should exhibit an understanding of the regulatory pharmacovigilance process for both pre-marketed and post-marketed stages of a product.
- experience working with regulatory affairs departments, product safety related departments, or regulatory submissions is highly desired.
- experience with data-mining or statistical signal detection products is desirable.
- demonstrated track record of success working with senior level management in a fast paced growth environment is essential.
- full sales cycle experience is required (prospect, identify opportunities, propose solutions, negotiate, close).
- strong, quality-oriented proposal writing and proposal management experience.
- ambitious, driven and self-motivated personality is required.
- college degree or equivalent experience required.
- willing to travel throughout the us, estimated up to 80%.
- background in software as a service (saas) market is preferred.
**we offer**:
- competitive base salary + commission.
- benefits: 100% medical/dental for employee and his/her family.
Interested applicants should reply with a brief summary of their relevant experience and attach their latest cv on zintro.
Please note: this position is only open to u.S. And u.K residents seeking full-time employment. No consultants please.
+49 Other ResponsesPharmaceutical Industry
Hi zintro expert,the zintro blog needs you! we are looking for expert opinions on the news mentioned below and would like to include your point of view.
we realize your time is valuable, so here is a brief summary of what we are looking for:
*a brief answer to the prompt about 1-2 paragraphs including your full name*participation is voluntary no payment will be involved*if chosen, you will be named in the post and we'll include a link to your zintro profile which will generate more visitors for you
topic and prompt
teva pharmaceutical industries ltd. And active biotech ab said monday they were ending the higher-dose portions of two multiple-sclerosis studies with the drug laquinimod after eight patients suffered nonfatal cardiovascular events.The companies said the incidents occurred in the higher-dose components of a phase 3 and a phase 2 clinical trial. The lower-dose and placebo components of the tests will continue.Phase 3 clinical trials are typically the last phase before a drug gets approval from the u.S. Food and drug administration.Teva shares fell 1.3% in early trading in new york, and active biotech shares fell by about one-third in stockholm.Laquinimod is a once-daily oral drug being developed for treating multiple sclerosis and huntington disease.
What are your thoughts?
Getting your name and expert opinion published on our blog is a great marketing opportunity. if interested, please send a response to the prompt via znotes within 1-2 days.Don't forget to include your full name.If you have any questions, please let us know.Thank you!
the zintro blog team
wondering what the post would look like? Here is a sample: http://blog.Zintro.Com/2014/08/14/rosetta-completes-10-year-trip-deep-space/>
+7 Other ResponsesPharmaceutical Development
I work at a human capital sourcing firm and am trying to find an expert or a consultant that can help me answer some questions about a potential investment.
I am looking for someone who can help me better understand single-source providers of medical information, pharmacovigilance, and regulatory compliance concerning pharmaceutical development. If a candidate has international experience, experience in both pv and mi, experience in asia would be a huge plus, but not mandatory.
+27 Other ResponsesPharmaceutical Market Access
Director, market access opportunity onsite in california, usa.
Overview:
the director market access will be a strategic business leader responsible for developing a comprehensive reimbursement, pricing, contracting, and distribution strategy for heplisav-b in the us to support launch in 2016. In addition, the director market access will provide guidance and insights to support commercial planning for pipeline products.
Responsibilities:
build out the infrastructure for the pricing, contracting, distribution and payer team.
Develop and execute market access strategies focused on reimbursement, pricing, contracting, and commercial distribution related to heplisav-b and future pipeline products across multiple disease states.
Apply deep understanding of national and local reimbursement trends and policies, payer coding and billing, and newly forming health care delivery models to develop managed market strategies.
Lead development and execution of contracting strategy for heplisav-b and future pipeline products.
Lead all aspects of payer coverage to support appropriate reimbursement of heplisav-b.
Develop dossier and other materials as needed to support payer acceptance.
Responsible for all distributor and gpo accounts, including contract negotiations, ongoing relationship management, and day to day operational activities.
Execute retail pharmacy channel distribution strategy in conjunction with product marketing.
Manage 3pl activities related to interactions with distribution network.
Work with commercial analytics to develop metrics/dashboards to assess performance of pricing and contracting strategy.
Qualifications:
at least 10 years of experience in the biotech or pharmaceutical industry;
at least 5 years’ experience in a market access/reimbursement/key account position with proven success
ba/bs with relevant experience;
understanding of billing and coding with experience in the implementation of pricing and contracting strategy;
comprehensive knowledge of us healthcare reimbursement system in both commercial and government payer;
demonstrated experience with specialty pharmacy and wholesalers.
+6 Other ResponsesPharmaceuticals Reverse Logistics
We are looking to do multiple paid phone consultations with experts from pharmaceutical returns providers with recent experience not more than 2 years ago. We would like to get a better understanding of learning about the operational capability and capacity of different niche market players to handle returns of controlled substances prescriptions on behalf of retailers and manufacturers.
This is a 1-hour paid phone consult. Please consider summarizing your relevant experience with short answers to the questions below:
1. Can you discuss how pharma companies generate data for overstocked, expired and in-dated pharmaceutical products?
2. Can you share the major challenges in handling returns of controlled substances prescriptions on behalf of retailers and manufacturers?
3. Can share your insight on the operational capability and capacity of different niche market players?
+26 Other ResponsesPharma Qualitative Study
We are seeking highly specialized experts with experience in the life sciences industry - must meet below specifications
location: usa - san fransisco bay area, los angeles, philadelphia, new york, boston.
Industry: pharmaceuticals, contract development and manufacturing organizations (cdmos)/clinical research organizations (cros), and life science market research.
Testing availability: late june - early july
study 2: qualitative study - one on one either telephonic or in-person interviews
**respondent profile**:
cost estimates for both tdi (telephonic interviews) and idi (in person interviews) with 8 respondents, 2 each from clinical trial supply managers/coordinators/directors, procurement contacts / outsourcing managers / directors, clinical / pre-clinical teams, senior executives (pharma/biotech/cro)
**expert's job titles**:
1) clinical trial supply managers / coordinators / directors
2) procurement contacts / outsourcing managers / directors
3) clinical / pre-clinical teams
4) senior executives
**experts must have a clear understanding of the following topics (doesn't have to be an expert at each level, but at least one, also a basic understanding of others)**:
a. Api services & chemical development – all stages of drug development for small molecules, potent and cytotoxic compounds, and peptides
b. Pharmaceutical development – development cycle of clinical candidate into an optimum formulation and clinical stages manufacturing
c. Analytical services – analytical services supporting drug substance (api) and drug product development including cmc regulatory filings
d. Clinical trial supply – clinical supplies, packaging, distribution and delivery of clinical protocols, supply chain management.
E. Clinical technologies - solutions for patient enrollment, screening randomization, drug assessment etc.
F. Commercial services – api supply, manufacturing, testing and packaging to end-user distribution.
+18 Other ResponsesPharma/biotech Insights And Analytics
We are looking to do multiple paid phone consultations to gain a better understanding of the insights and analytics of major pharma and biotech companies such as sanofi, johnsons & johnsons, bristol meyers squibb, pfizer, merck.
We would be particularly interested to speak with senior executives responsible for analyzing insights and data around marketing. Examples include early patient identification, patient journey, action analytics, integrated forecasting, market research, commercial analytics, sales force effectiveness, etc.
Ideally someone in a decision-making capacity or heavily influential to decision making in terms of marketing analytics from the pharmaceutical companies mentioned above. Also, senior-level people from major data analytics companies engaged in life sciences such as mu sigma, shyft analytics, etc. Responsible for platforms around pharma analytics/insights or rwe focused technology platforms.
This would be for a 1-hour paid phone consult. To demonstrate your relevance, please consider briefly answering the questions below:
1. What is the extent of your experience that will showcase your overall knowledge in handling marketing insights and analytics for pharma and/or biotech products/companies? Please answer briefly.
2. Which providers or consultants do you currently use to obtain marketing insights and analytics (e.G. Mu sigma, shyft analytics, axtria, analytical wizards, etc.)? If you do not actively use them are you aware of the different marketing insights and analytics companies/platforms?
3. Are you familiar or knowledgeable with any of the following analytics software company: mu sigma, shyft analytics, analytical wizards, or axtria? Kindly specify.
***referrals are highly appreciated.
+15 Other Responses
